Sara's List 2021
12 startups picked for 5x-in-5-years potential
Sara Parr's 2021 picks on My First Million: private companies she thought could 5x over five years, turning $200K of equity into $1M. Evaluating an offer at one of these? Compare equity upside side-by-side.
Selection criteria:
- Product-market fit
- Well-funded
- Growing
- 5x potential over 5 years
Source: My First Million — Sara Parr ↗ (2021)
Members
| # | Company | Valuation | Latest round | HQ |
|---|---|---|---|---|
| 1 | Flexport | $8B | Series E | San Francisco, CA |
| 2 | Zapier | $106M | Series B | San Francisco, CA |
| 3 | Uniswap | $641M | Series B | New York, NY |
| 4 | Anduril | $31B | Series F | Costa Mesa, CA |
| 5 | Replit | $9B | Series C | San Francisco, CA |
| 6 | Airtable | $12B | Series F | San Francisco, CA |
| 7 | Figma | $11.17B | Series E | San Francisco, CA |
| 8 | Rippling | $17B | Series F | San Francisco, CA |
| 9 | Faire | $5B | Series G | San Francisco, CA |
| 10 | OneTrust | $5B | Series C | Atlanta, GA |
Direct competitors
For each pick, four direct competitors outside the list — because the sharpest equity comparison is against the company you'd actually choose between.
| Pick | Direct competitors |
|---|---|
| Flexport | vs ShipBob , vs STORD , vs Project44 , vs FourKites |
| Zapier | vs Workato , vs n8n , vs Retool , vs Tray.io |
| Uniswap | vs LayerZero , vs Consensys Software , vs Alchemy , vs Chainalysis |
| Anduril | vs Shield AI , vs Helsing , vs Saronic , vs Skydio |
| Replit | vs Vercel , vs Cursor , vs Warp.Dev , vs Lovable |
| Airtable | vs Notion , vs Retool , vs Clickup , vs Workato |
| Figma | vs Canva , vs Miro , vs Webflow , vs Notion |
| Rippling | vs Gusto , vs Deel , vs Remote , vs Justworks |
| Faire | vs SHEIN , vs Whatnot , vs GOAT , vs StockX |
| OneTrust | vs Vanta , vs Drata , vs BigID , vs Immuta |
Head-to-head comparisons
Every pairwise comparison in this set, side-by-side.
Related
Compiled from public sources. Valuations and figures may be outdated. Not investment advice.
Inclusion in a set is editorial — not a recommendation.